Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (611-620 of 723) with videos related to

Pageof 73
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experienceF Labrie, A Dupont, L Cusan, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1997
Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor betaG B Tremblay, A Tremblay, N G Copeland, et al.
The Journal of Endocrinology|August 6, 1998
Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the ratC Martel, A Sourla, G Pelletier, et al.
Advances in Cyclic Nucleotide Research|January 1, 1975
Role of cyclic AMP in the action of hypothalamic regulatory hormonesF Labrie, P Borgeat, A Lemay, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1990
Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genesV Luu-The, C Labrie, J Simard, et al.
Steroids|June 10, 1998
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during agingF Labrie, A Bélanger, V Luu-The, et al.
Nature Genetics|July 1, 1992
Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase geneE Rhéaume, J Simard, Y Morel, et al.
Molecular and Cellular Endocrinology|February 1, 1991
Characterization of macaque 3 beta-hydroxy-5-ene steroid dehydrogenase/delta 5-delta 4 isomerase: structure and expression in steroidogenic and peripheral tissues in primateJ Simard, M H Melner, N Breton, et al.
Endocrinology|May 16, 1998
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouseC Martel, C Labrie, A Bélanger, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal womenS Moorjani, A Dupont, F Labrie, et al.
Pageof 73

Showing results (611-620 of 723) with videos related to

Sort By:
Pageof 73
Progress in Clinical and Biological Research|January 1, 1988
Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experienceF Labrie, A Dupont, L Cusan, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1997
Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor betaG B Tremblay, A Tremblay, N G Copeland, et al.
The Journal of Endocrinology|August 6, 1998
Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the ratC Martel, A Sourla, G Pelletier, et al.
Advances in Cyclic Nucleotide Research|January 1, 1975
Role of cyclic AMP in the action of hypothalamic regulatory hormonesF Labrie, P Borgeat, A Lemay, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1990
Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genesV Luu-The, C Labrie, J Simard, et al.
Steroids|June 10, 1998
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during agingF Labrie, A Bélanger, V Luu-The, et al.
Nature Genetics|July 1, 1992
Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase geneE Rhéaume, J Simard, Y Morel, et al.
Molecular and Cellular Endocrinology|February 1, 1991
Characterization of macaque 3 beta-hydroxy-5-ene steroid dehydrogenase/delta 5-delta 4 isomerase: structure and expression in steroidogenic and peripheral tissues in primateJ Simard, M H Melner, N Breton, et al.
Endocrinology|May 16, 1998
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouseC Martel, C Labrie, A Bélanger, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal womenS Moorjani, A Dupont, F Labrie, et al.
Pageof 73